STERIS plc and its Board of Directors strongly oppose all forms of slavery, servitude, forced labor and human trafficking ("Slavery and Human Trafficking"). This Statement is made pursuant to the Modern Slavery Act of 2015 (“Act”) and sets out the steps that STERIS plc (together with all of its direct and indirect wholly-owned subsidiaries, the “Company” or “STERIS”) have taken to prevent modern Slavery and Human Trafficking in its business and supply chains in 2017. The Company recognizes that Slavery and Human Trafficking can occur in many forms. References in this Statement to "Slavery and Human Trafficking" are intended to encompass any form of coerced labor.
STERIS is a leading provider of infection prevention and other procedural products and services. STERIS’s mission is to help its Customers create a healthier and safer world by providing innovative healthcare and life science product and service solutions around the globe. STERIS offers its Customers a unique mix of innovative capital equipment products, such as sterilizers and surgical tables, and connectivity solutions such as operating room integration; consumable products, such as detergents, gastrointestinal endoscopy accessories, barrier product solutions, and other products and services, including: equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair solutions, laboratory testing services, and on-site and off-site reprocessing. STERIS manufactures, sources, and provides services and solutions to its Customers globally. The Company’s supply chains are extensive and global, including thousands of suppliers.
The Company is committed to implementing and maintaining systems and processes to avoid complicity in Slavery and Human Trafficking related to our operations and those of our affiliate commercial organizations, as well as any such activity occurring within our supply chains or the supply chains of our affiliates.
The Company maintains a Code of Business Conduct ("Code") and the Code is reviewed and updated as needed every other year. New employees are required to acknowledge their understanding of the Code and commit to adhering to the Code’s policies. The Company requires all employees to participate in a training program every other year and to attest to their understanding of, and adherence to, the Code. The Code requires all employees, among other obligations, to act lawfully, ethically, and responsibly in all of their business practices, and comply with applicable laws.
The Code also specifically provides that a failure by any employee to comply with laws or regulations governing the Company's business or the Code may result in disciplinary action, termination, and if warranted, legal proceedings. The Code also provides for communication channels to be utilized in case of any violations including the Company's Global Compliance, Human Resources, Audit and Legal Departments. To further encourage compliance and the reporting of violations, the Company maintains an Integrity Helpline (reporting system) and website. A strict anti-retaliation policy is followed, and reports may be made anonymously. All reports are promptly addressed by the Company’s ethics committee and reviewed each quarter by the Compliance Committee of the Company's Board of Directors. STERIS has not received any reports with respect to our businesses regarding Slavery or Human Trafficking.
The Company has no reason to believe that any Slavery or Human Trafficking is occurring in any of the Company's businesses. Nonetheless, during 2017, the Company has taken the following steps to detect and prevent any violations of the Act or conditions that may give rise to a violation of the Act:
The Company will not work with any organization it finds to be knowingly involved with Slavery or Human Trafficking. STERIS encourages everyone, including employees, contractors, suppliers and clients, to report in good faith any issues or concerns regarding Slavery or Human Trafficking.
The Company Directors and Senior Management are responsible for ensuring that the activities of STERIS plc and its subsidiaries continue to comply with the Act. To this end, STERIS will continue to provide adequate resources, the commitment of its employees, training, and investment to ensure compliance to the Act.
Signed: Date: September 27, 2017
Walter M Rosebrough, Jr.
President, CEO and Director